The serum and peritoneal fluid HMGB1 levels peak in the early stage of acute peritonitis and gradually decrease with treatment, suggesting that HMGB1 may be used as a biomarker to evaluate peritoneal status and therapy response.205. Here, HMGB1 is linked to peritonitis.